{"id":122,"date":"2024-01-07T10:00:00","date_gmt":"2024-01-07T10:00:00","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=122"},"modified":"2025-09-01T10:34:22","modified_gmt":"2025-09-01T10:34:22","slug":"china-bd-2024-argo-and-novartis-enters-a-4-billion-usd-license-on-two-rnai-programs","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2024\/122.html","title":{"rendered":"[China BD 2024] Argo and Novartis enters a 4 billion USD license on two RNAi programs"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Announced Date: 2024-01-07 (January 7, 2024)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Name: Two RNAi programs\u00a0 (RNA interference)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensor: Argo (Shanghai Argo Biopharmaceutical Co., Ltd. , China)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensee (Buyer): \u00a0Novartis (Novartis Pharma AG)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of Authority:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under the first agreement, Argo has granted Novartis exclusive global licenses to develop and commercialize a\u00a0Phase 1 stage program. The first agreement also includes a research collaboration and Novartis also receives an option to potentially license compounds directed against up to two additional targets for cardiovascular disease treatment. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under the second agreement, Argo granted Novartis an exclusive ex-Greater China license to develop and commercialize a Phase 1\/2a clinical-stage program for cardiovascular disease treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payment Detail:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Upfront payment of\u00a0$185 million,<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Total up to $4.165 billion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">And tiered royalties.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.argobiopharma.com\/news\/103.html\">https:\/\/www.argobiopharma.com\/news\/103.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2024-01-07 (January 7, 2024) Asset Name: Two RNAi programs\u00a0 (RNA interference) Licensor: Argo (Shanghai &hellip; <a title=\"[China BD 2024] Argo and Novartis enters a 4 billion USD license on two RNAi programs\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2024\/122.html\"><span class=\"screen-reader-text\">[China BD 2024] Argo and Novartis enters a 4 billion USD license on two RNAi programs<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-122","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=122"}],"version-history":[{"count":1,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/122\/revisions"}],"predecessor-version":[{"id":123,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/122\/revisions\/123"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}